استكشف المجموعة الواسعة من العناوين المتاحة.

Background Dragon blood is a red fruit resin from the palm tree Daemonorops draco and is a herbal ingredient used in the traditional Chinese medicine, “Jinchuang Ointment,” which is used to treat non-healing diabetic wounds. According to the Taiwan Herbal Pharmacopeia, the dracorhodin content in dragon blood should exceed 1.0%. Results Our findings indicate that dracorhodin and dragon blood crude extracts can stimulate glucose uptake in mouse muscle cells (C2C12) and primary rat aortic smooth muscle cells (RSMC). Dracorhodin is not the only active compound in dragon blood crude extracts from D. draco . Next, we orally administered crude dragon blood extracts to male B6 mice. The experimental group displayed a decreasing trend in fasting blood glucose levels from the second to tenth week. In summary, crude extracts of dragon blood from D. draco demonstrated in vivo hypoglycemic effects in B6 male mice. Conclusions We provide a scientific basis “Jinchuang ointment” in treating non-healing wounds in patients with diabetes.

When doctors are fatigued, they often make diagnostic errors. Similarly, pharmacists may also make mistakes in dispensing medication. Therefore, object segmentation plays a vital role in many healthcare-related areas, such as symptom analysis in biomedical imaging and drug classification. However, many traditional deep-learning algorithms use a single view of an image for segmentation or classification. When the image is blurry or incomplete, these algorithms fail to segment the pathological area or the shape of the drugs accurately, which can then affect subsequent treatment plans. Consequently, we propose the Fuzzy DBNet, which combines the dual butterfly network and the fuzzy ASPP in a deep-learning network and processes images from both sides of an object simultaneously. Our experiments used multi-category pill and lung X-ray datasets for training. The average Dice coefficient of our proposed model reached 95.05% in multi-pill segmentation and 97.05% in lung segmentation. The results showed that our proposed model outperformed other state-of-the-art networks in both applications, demonstrating that our model can use multiple views of an image to obtain image segmentation or identification.

This study mixed acetylacetone (Acac, 1, 2, and 3 mL) and graphene powder (GP, 0 wt.%, 0.001 wt.%, 0.003 wt.% and 0.005 wt.%) with TiO2 mesoporous (TiO2 powders: 20 g and particle size ~30 nm) to enhance the optoelectronic performances of dye sensitized solar cells (DSSC). Sponge-like structure TiO2 mesoporous layers is a requirement for obtaining high efficiency DSSC, which ia synthesized by spin-coating techniques. The dense TiO2 blocking layer (using peroxo-titanium complex) has a uniform, dense structure and completely adheres to the substrates to avoid charge recombination. The X-ray diffraction (XRD) and transmission electron microscopy (TEM) analyses of the TiO2 films display the anatase type phase with preferred orientation along the (101) direction. After being ball milled, the TiO2 mesoporous particle size almost remains unchanged. For mixing the Acac with TiO2, the Raman intensity relatively increased, and the band gap energy (Eg) value decreased from 3.223 eV (for pure TiO2) to 3.076 eV (for 2 mL Acac). Raman spectroscopy is used to evaluate the GP elements. It can be seen the intensity ratio (ID/IG) and (I2D/IG) was enhanced when the GP concentration increased. Using mixed Acac 2 mL and GP 0.003 wt.% with a TiO2 mesoporous, led to increases in the open circuit voltage (VOC), short circuit current density (JSC) and fill factor (FF). If a fluorine-doped tin oxide is used instead of an indium tin oxide glass substrate, the photovoltaic efficiency of DSSC increases from 5.45% to 7.24%.

Aim： To evaluate the pharmacokinetic interactions between theophylline and antofloxacin in vivo and in vitro. Methods： A randomized, 5-day treatment and 3-way crossover design was documented in 12 healthy subjects. The subjects were orally administered with antofloxacin （400 mg on d I and 200 mg on d 2 to 5）, theophylline （100 mg twice a day and morning dose 200 mg on d I and 5）, or theophylline plus antofloxacin. The plasma and urinary pharmacokinetics of antofloxacin and theophylline were characterized after the first and last dose. The effect of antofloxacin on theophylline metabolism was also investigated in pooled human liver microsomes. Results： The 5-day treatment with antofloxacin significantly increased the area of the plasma concentration-time curve and peak plasma concentration of theophylline, accompanied by a decrease in the excretion of theophylline metabolites. On the contrary, theophylline did not affect the pharmacokinetics of antofloxacin. In vitro studies using pooled human hepatic microsomes demonstrated that antofloxacin was a weak reversible and mechanism-based inhibitor of CYPIA2. The clinical interaction between theophylline and antofloxacin was further validated by the in vitro results. Conclusion： The results showed that antofloxacin increases the plasma theophylline concentration, partly by acting as a mechanismbased inhibitor of CYP1A2.

Introduction Hydroxychloroquine (HCQ), 4-aminoquinoline, is an antimalarial drug and has become a basic therapy for rheumatic disease treatment. It can stabilize the condition of SLE patients and reduce the chances of patient relapse through its immunosuppressive function and antiinflammatory effects. This drug was absorbed completely and rapidly by oral administration, but has a prolonged half-life for elimination. The objective of this study was to evaluate the pharmacokinetic parameters and relative bioequivalence of a new generic (test) formulation with the branded (reference) formulation of HCQ in healthy Chinese male volunteers. This study was designed to acquire regulatory approval for the test formulation. Methods This study was conducted with a randomized, single-dose, two-period, and crossover design. The male subjects were randomly assigned to two groups at a 1:1 ratio to receive 0.2 g hydroxychloroquine sulfate tablets (0.1 g/piece) of the two formulations after a 3-month washout period then administered the alternate formulation. Study drugs were administered after overnight fasting (over 10 h). Plasma concentrations of hydroxychloroquine were measured by a validated LC-MS/MS method. The following pharmacokinetic properties were determined by a noncompartmental pharmacokinetic method: C max , T max , AUC 0– t , AUC 0–∝ , and t 1/2 . The bioequivalence between the test and reference products was assessed based on the following parameters: C max , AUC0–60d, and AUC 0–∝ using the ANOVA method. If the 90% CI for AUC 0– t was within 80–125% and for C max was within 70–143% of the statistical interval proposed by the SFDA, the two formulations were assumed bioequivalent. Concerning the main pharmacokinetic charateristics of hydroxychloroquine, a long half-life drug, the pharmacokinetic parameters of 0–72 h were determined according to the FDA. Furthermore, a comparison was made between the parameters at 0–60 days and 0–72 h to evaluate whether a truncated AUC method can be applied to estimate the relative bioavailability of HCQ. Tolerability was assessed by monitoring vital signs and laboratory tests and by questioning subjects about adverse events. Results The 90% CI of C max for HCQ is 103.8–142.3%; the AUC0–60 is 100–114.2% and AUC 0–∝ 100–115.5%. Both met the criteria according to the SFDA’s guidelines for bioequivalence. The relative bioavailability was 109.5% (according to AUC 0–60d ) and 110.7% (according to AUC 0–∝ ). No serious or unexpected adverse events were observed. Conclusions In this study, the pharmacokinetic studies and results were conducted so that the test and reference formulations of HCQ met the Chinese criteria for assuming bioequivalence. Both formulations were well tolerated in the population studies.

Background: Inflammatory events may contribute to the pathogenesis of dementia and interleukin-1 (IL-1) may exert both neurotoxic and neuroprotective effects. We investigated whether IL-1α –889 C/T and IL-1β –511 C/T promoter polymorphisms are associated with the risk of Alzheimer’s disease (AD) and vascular dementia (VaD). Methods: AD patients (n = 219) and VaD patients (n = 82), who fulfilled the criteria of the NINCDS-ADRDA and NINDS-AIREN, and ethnic-matched and nondemented controls (n = 209) were analyzed by means of genotype association method. Results: No significant difference in the genotype distribution of the analyzed single nucleotide polymorphisms was found between AD or VaD cases and controls. However, the frequency of the IL-1α –889 CT genotype was notably lower in VaD patients aged over 70 years than the age-matched controls (9.1 vs. 22.9%, p = 0.036) andtheIL-1α –889 CT genotype demonstrated a trend toward decrease in risk of developing VaD (odds ratio: 0.34; 95% confidence interval: 0.12–0.83, p = 0.026). Multivariate analysis revealed that the IL-1β –511T-carrying genotype slightly strengthens the negative association of the IL-1α –889 CT genotype with VaD (odds ratio: 0.26; 95% confidence interval: 0.08–0.79, p = 0.024). Conclusion: Our data suggest a protective role of the IL-1α –889 CT genotype in VaD susceptibility among Taiwanese aged over 70 years.

Abstract The demands of the technologies of the future such as autonomous vehicles, Internet of Things and mixed reality require communications platforms equipped to handle huge quantities of data. Higher frequency communication bands are attractive but have limitations in terms of data loss particularly during wireless transmission. Free-space optical (FSO) communication, which transmits optical signals through free-space by modulating laser light, is one option for better wireless signal delivery. Here we report a platform combining multiple transmission media of 40-km single-mode fibre, with 1.2-km FSO communication, and short range (0.5-2 m) radio-frequency wireless. We demonstrate sufficiently low bit error rates and error vector magnitudes at sub-terahertz frequencies, satisfying the requirement of 5 G new radio communications applications.

Amorphous spherical silica powders were prepared by inductively coupled thermal plasma treatment at a radio frequency of 36.2 MHz. The effects of the added content of hydrogen and nitrogen into argon(serving as the sheath gas), as well as the carrier gas flow rate, on the spheroidization rate of silica powders, were investigated. The prepared silica powders before and after plasma treatment were examined by scanning electron microscopy, X-ray diffraction, and laser granulometric analysis. Results indicated that the average size of the silica particles increased, and the transformation of crystals into the amorphous state occurred after plasma treatment. Discharge image processing was employed to analyze the effect of the plasma temperature field on the spheroidization rate. The spheroidization rate of the silica powder increased with the increase of the hydrogen content in the sheath gas. On the other hand, the spheroidization rate of the silica power first increased and then decreased with the increase of the nitrogen content in the sheath gas. Moreover, the amorphous content increased with the increase of the spheroidization rate of the silica powder.